Description of Research Expertise:
RESEARCH INTERESTS:
As a Physician-Scientist, I conduct brain tumor research and specialize in treatment of patients with intracranial malignancies. I have scientific expertise in the areas of signal transduction, molecular therapeutics, brain tumor biology, and radiation biology. As a translational researcher, I am actively involved in basic mechanistic studies, the application of in vivo imaging methods to preclinical studies in relevant biological models of cancer, and early phase clinical trials in intracranial malignancies. In a broad sense, my research focuses on understanding the underlying mechanisms whereby cancers demonstrate resistance to radiation and chemotherapy. This information will give us a framework to develop ways to target oncogenic pathways that lead to therapeutic resistance and identify potential molecular interventions that may reduce the normal tissue complications of radiation therapy. One research focus concerns the elucidation of mechanism(s) whereby the Integrated Stress Response (ISR) modulates death receptor expression, and leveraging this understanding therapeutically. A second area of focus is the identification and characterization of circulating tumor cells (CTCs) in the peripheral blood of cancer patients including those with primary brain tumors to gain prognostic and predictive information. Finally, my laboratory has an ongoing project focused on the application and preclinical testing of novel theranostic gold nanoparticle agents in the imaging and radiosensitization of tumors and overcoming challenges of therapeutic access through the blood brain barrier. This includes evaluation of the efficacy of novel radiotheranostic nanoparticle combinations in preclinical animal models and determination of timing, dosage, and in vivo mechanisms of anti-tumor action.
Selected Publications:
Zeh R, Sheikh S, Xia L, Pierce J, Newton A, Predina J, Cho S, Nasrallah M, Singhal S, Dorsey J, Lee JYK: The second window ICG technique demonstrates a
broad plateau period for near infrared fluorescence tumor contrast in
glioblastoma PloS One 12 (7): 2017.
Sattiraju A, Xiong X, Pandya DN, Wadas TJ, Xuan A, Sun Y, Jung Y, Solingapuram Sai KK, Dorsey JF, Li KC, Mintz A: Alpha particle enhanced Blood Brain/Tumor Barrier permeabilization in glioblastomas using integrin alpha-v beta-3 targeted liposomes Mol Cancer Ther. : 2017.
Chinniah C, Aguarin L, Cheng P, DeCesaris C, Cutillo A, Berman AT, Frick M, Levin WP, Cengel KA, Hahn SM, Dorsey JF, Kao GD, Simone CB 2nd: Prospective Trial of Circulating Tumor Cells as a Biomarker for Early Detection of Recurrence in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiation Therapy Int J Radiat Oncol Biol Phys. 98 (1): 2017.
Sun Lova, Joh Daniel Y, Al-Zaki Ajlan, Stangl Melissa, Murty Surya, Davis James J, Baumann Brian C, Alonso-Basanta Michelle, Kaol Gary D, Tsourkas Andrew, Dorsey Jay F: Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme. J Biomed Nanotechnol 12 (2): 347-56,2016.
Xu Melody J, Dorsey Jay F, Amaravadi Ravi, Karakousis Giorgos, Simone Charles B, Xu Xiaowei, Xu Wei, Carpenter Erica L, Schuchter Lynn, Kao Gary D: Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma. Theoncologist 21 (1): 84-94,2016.
Ajlan W. Al Zaki, David P. Cormode, Andrew Tsourkas, Jay F. Dorsey: Nanoparticle-enhanced Radiotherapy Increasing the Therapeutic Ratio of Radiotherapy : 2016.
Chowdhury Imran H, Ojerholm Eric, McMillan Matthew T, Miller Denise, Kolker James D, Kurtz Goldie, Dorsey Jay F, Nagda Suneel N, Geiger Geoffrey A, Brem Steven, O'Rourke Donald M, Zager Eric L, Gangadhar Tara, Schuchter Lynn, Lee John Y K, Alonso-Basanta Michelle: Novel risk scores for survival and intracranial failure in patients treated with radiosurgery alone to melanoma brain metastases. Radiation oncology (London, England) 10 : 248,2015.
Lee John Y K, Sandhu Sukhmeet, Miller Denise, Solberg Timothy, Dorsey Jay F, Alonso-Basanta Michelle: Higher dose rate Gamma Knife radiosurgery may provide earlier and longer-lasting pain relief for patients with trigeminal neuralgia. J Neurosurg 123 (4): 961-8,2015.
Vogel J, Ojerholm E, Hollander A, Briola C, Mooij R, Bieda M, Kolker J, Nagda S, Geiger G, Dorsey J, Lustig R, O'Rourke DM, Brem S, Lee J, Alonso-Basanta M: Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastases Radiat Oncol 10 (1): 221,2015.
Simone Charles B, Dorsey Jay F: Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy. Annals Transl Med 3 (13): 172,2015.
View all publications